Literature DB >> 25948846

Headache in a young woman: leptomeningeal metastasis as the first presentation of underlying breast malignancy.

Poornima Mohan1, Marilina Antonelou2, Ophelia Dadzie3, Simon Dubrey4.   

Abstract

A 37-year-old woman presented with a 2-week history of persistent headache in an occipitotemporal distribution. The patient had experienced prior headaches and migraines, but this presentation was characterised by its intensity and duration. There was associated dizziness and blurring of vision in episodes occurring up to 4-5 times per day. Whole body cross-sectional CT imaging and MRI of neuronal axes were normal. Cerebrospinal fluid cytology demonstrated large abnormal pleomorphic cells expressing the tumour marker CA125. Positron emission tomography-fluorodeoxyglucose revealed bilateral axillary and cervical lymphadenopathy as well as increased uptake in the lateral regions of both breasts. These results correlated with MRI breast and mammography findings. Axillary lymph node biopsy showed poorly differentiated adenocarcinoma making the diagnosis of breast malignancy, the most likely primary site of metastatic leptomeningeal disease. In the 6-week interval between initial presentation and diagnosis, the patient deteriorated significantly with the new onset of facial nerve palsy and partial seizures. The treatment intent was palliative, focusing on symptom control with systemic chemotherapy and whole brain radiotherapy. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 25948846      PMCID: PMC4434292          DOI: 10.1136/bcr-2014-207643

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  23 in total

1.  Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.

Authors:  Hee-Jun Kim; Seock-Ah Im; Bhumsuk Keam; Yu-Jung Kim; Sae-Won Han; Tae Min Kim; Do-Youn Oh; Jee Hyun Kim; Se-Hoon Lee; Eui Kyu Chie; Wonshik Han; Dong-Wan Kim; Tae-You Kim; Dong-Young Noh; Dae Seog Heo; In Ae Park; Yung-Jue Bang; Sung Whan Ha
Journal:  J Neurooncol       Date:  2011-09-22       Impact factor: 4.130

2.  Clinical features and outcome of leptomeningeal metastasis in patients with breast cancer: a single center experience.

Authors:  Jae-Cheol Jo; Myoung Joo Kang; Jeong Eun Kim; Jin-Hee Ahn; Kyung Hae Jung; Gyungyub Gong; Hak Hee Kim; Seung Do Ahn; Su Ssan Kim; Byung Ho Son; Sei Hyun Ahn; Sung-Bae Kim
Journal:  Cancer Chemother Pharmacol       Date:  2013-05-14       Impact factor: 3.333

Review 3.  Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials.

Authors:  Marc Chamberlain; Riccardo Soffietti; Jeffrey Raizer; Roberta Rudà; Dieta Brandsma; Willem Boogerd; Sophie Taillibert; Morris D Groves; Emilie Le Rhun; Larry Junck; Martin van den Bent; Patrick Y Wen; Kurt A Jaeckle
Journal:  Neuro Oncol       Date:  2014-05-27       Impact factor: 12.300

4.  Cerebrospinal fluid tumor marker levels in predicting response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.

Authors:  Christos Kosmas; Nicolas B Tsavaris; George Tsakonas; Georgia Soukouli; Argyris Gassiamis; Nicolas Mylonakis; Athanasios Karabelis
Journal:  Med Sci Monit       Date:  2005-07-25

Review 5.  Leptomeningeal metastases from solid malignancy: a review.

Authors:  Sophie Taillibert; Florence Laigle-Donadey; Catherine Chodkiewicz; Marc Sanson; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

6.  MR imaging of leptomeningeal metastases: comparison of three sequences.

Authors:  Sanjay K Singh; Norman E Leeds; Lawrence E Ginsberg
Journal:  AJNR Am J Neuroradiol       Date:  2002-05       Impact factor: 3.825

Review 7.  Management of leptomeningeal malignancy.

Authors:  George Pentheroudakis; Nicholas Pavlidis
Journal:  Expert Opin Pharmacother       Date:  2005-06       Impact factor: 3.889

8.  Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers.

Authors:  Elena Corsini; Gaetano Bernardi; Paola Gaviani; Antonio Silvani; Ugo de Grazia; Emilio Ciusani; Danilo Croci; Andrea Salmaggi
Journal:  Clin Chem Lab Med       Date:  2009       Impact factor: 3.694

9.  Clinicopathologic characteristics and prognostic factors in 420 metastatic breast cancer patients with central nervous system metastasis.

Authors:  Kadri Altundag; Melissa L Bondy; Nadeem Q Mirza; Shu-Wan Kau; Kristine Broglio; Gabriel N Hortobagyi; Edgardo Rivera
Journal:  Cancer       Date:  2007-12-15       Impact factor: 6.860

Review 10.  Neoplastic meningitis.

Authors:  L Kim; M J Glantz
Journal:  Curr Treat Options Oncol       Date:  2001-12
View more
  3 in total

Review 1.  Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification?

Authors:  Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-03-08       Impact factor: 6.543

2.  "Pre-metastatic niches" in breast cancer: are they created by or prior to the tumour onset? "Flammer Syndrome" relevance to address the question.

Authors:  Rostyslav Bubnov; Jiri Polivka; Pavol Zubor; Katarzyna Konieczka; Olga Golubnitschaja
Journal:  EPMA J       Date:  2017-05-02       Impact factor: 6.543

3.  Leptomeningeal Disease as an Initial Presenting Manifestation in Breast Cancer.

Authors:  Jasmine Shrestha; Asis Shrestha; Pratul Karki; Ajay Dhakal
Journal:  Cureus       Date:  2021-11-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.